Flagship Pioneering

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

Eric Topol boards Flagship as advisor—Chutes & Ladders

Mar 20, 2026 8:30am

Alltrna CEO departs amid 35% layoff round

Mar 6, 2026 8:30pm

Behind Generate's 'feverish' race to raise $400M IPO

Feb 27, 2026 3:36am

Generate plans $425M IPO to bankroll phase 3 asthma trials

Feb 23, 2026 9:42am

Flagship-founded antibody biotech Generate is latest to mull IPO

Feb 5, 2026 9:20am